Otsuka Holdings Co., Ltd. Stock

Equities

4578

JP3188220002

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-06-07 am EDT 5-day change 1st Jan Change
6,413 JPY -0.77% Intraday chart for Otsuka Holdings Co., Ltd. -0.94% +21.25%
Sales 2024 * 2,206B 14.07B Sales 2025 * 2,183B 13.92B Capitalization 3,479B 22.18B
Net income 2024 * 226B 1.44B Net income 2025 * 240B 1.53B EV / Sales 2024 * 1.35 x
Net cash position 2024 * 497B 3.17B Net cash position 2025 * 646B 4.12B EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
15.1 x
P/E ratio 2025 *
14.2 x
Employees 34,388
Yield 2024 *
1.84%
Yield 2025 *
1.89%
Free-Float 81.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.77%
1 week-0.94%
Current month-0.94%
1 month+0.45%
3 months+5.51%
6 months+14.87%
Current year+21.25%
More quotes
1 week
6 287.00
Extreme 6287
6 629.00
1 month
6 075.00
Extreme 6075
6 708.00
Current year
5 030.00
Extreme 5030
6 845.00
1 year
4 857.00
Extreme 4857
6 845.00
3 years
3 827.00
Extreme 3827
6 845.00
5 years
3 224.00
Extreme 3224
6 845.00
10 years
2 936.00
Extreme 2936
6 845.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 08-07-07
Director of Finance/CFO 62 15-02-28
Chairman 59 08-07-07
Members of the board TitleAgeSince
Chief Executive Officer 74 08-07-07
Chairman 59 08-07-07
Director/Board Member 57 17-03-29
More insiders
Date Price Change Volume
24-06-07 6,413 -0.77% 1,687,700
24-06-06 6,463 -1.58% 1,196,100
24-06-05 6,567 +1.61% 976,300
24-06-04 6,463 -0.29% 888,900
24-06-03 6,482 +0.12% 855,200

Delayed Quote Japan Exchange, June 07, 2024 at 02:00 am EDT

More quotes
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity: - manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices; - manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements; - production of mineral waters, beverages and foods (2.1%); - other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc. Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%). Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
6,413 JPY
Average target price
6,473 JPY
Spread / Average Target
+0.93%
Consensus